Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke Meyer

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Clinical Lung Cancer|September 11, 2022
Study Design and Rationale for the PACE-LUNG Trial: A Multicenter, Single-Arm, Phase II Clinical Trial Evaluating the Efficacy of Additional Chemotherapy for Patients with EGFRm NSCLC with the Continued Presence of Plasma ctDNA EGFRm at Week 3 After Start of Osimertinib First-Line TreatmentFabian Acker, Lukas Aguinarte, Friederike Althoff, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 14, 2011
The embryonic stem cell test as tool to assess structure-dependent teratogenicity: the case of valproic acidChristian Riebeling, Ralph Pirow, Klaus Becker, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Clinical Lung Cancer|September 11, 2022
Study Design and Rationale for the PACE-LUNG Trial: A Multicenter, Single-Arm, Phase II Clinical Trial Evaluating the Efficacy of Additional Chemotherapy for Patients with EGFRm NSCLC with the Continued Presence of Plasma ctDNA EGFRm at Week 3 After Start of Osimertinib First-Line TreatmentFabian Acker, Lukas Aguinarte, Friederike Althoff, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 14, 2011
The embryonic stem cell test as tool to assess structure-dependent teratogenicity: the case of valproic acidChristian Riebeling, Ralph Pirow, Klaus Becker, et al.
Pageof 2